Our collaborator Dr Jordi Riba presented these ground-breaking results at the Interdisciplinary Conference on Psychedelics Research last week in Amsterdam. The results are, as yet, unpublished but you can have a sneak peak at the slides from Jordi Riba’s presentation here.
The study was conducted within the framework of the Beckley/Sant Pau Research Programme and in collaboration with the Spanish National Research Council. In the study participated the following researchers from the Spanish National Research Council (CSIC): Jose Morales-García, María Isabel Rodriguez-Franco, Ana Pérez-Castillo and Mario de la Fuente Revenga. They found that harmine and tetrahydroharmine, [...]
Support the campaign here (Campaign Complete. This project has ended on April 19, 2015. No more contributions can be made).
The mind expanding hallucinogenic substance called LSD-25 has been considered by many to be the shamanistic sacrament of our generation. For the first time ever scientists are researching how LSD affects the brain in order to further it’s potential to be used medicinally against depression and addiction.
The first controlled LSD study in over 40 years was recently published in the Journal of Nervous and Mental Disease. The study consisted of 12 participants who suffer from “anxiety, depression, as well as unresolved family and relationship issues” resulting from life-threatening illness. To no surprise by many of our readers, the study observed a significant drop in anxiety levels among the participants, many having a lasting effect.
The study focused on individuals who had no alcohol or drug dependence and who were facing serious life-threatening illnesses. The vast majority of the participants had never tried psychedelics. The clinical trial was a “phase 2 [...]
It’d be a monumental leap forward in the ongoing agony and ecstasy of treating wartime post-traumatic stress with psychedelics. They’d be somewhat unlikely partners, sure, but to hear that the Multidisciplinary Association for Psychedelic Studies has reached out to the Pentagon makes a lot of sense. MAPS needs PTSD-affected troops to fill out its trials, something the Pentagon undoubtedly can provide if it wants to.
Rick Doblin, MAPS founder and executive director, says the non-profit research group is in talks with the Pentagon about a potential study involving active duty soldiers with PTSD. He says that MAPS, which has been at the forefront of MDMA-, LSD-, and [...]
A psychedelic drink used for centuries in healing ceremonies is now attracting the attention of biomedical scientists as a possible treatment for depression. Researchers from Brazil last month published results from the first clinical test of a potential therapeutic benefit for ayahuasca, a South American plant-based brew. Although the study included just six volunteers and no placebo group, the scientists say that the drink began to reduce depression in patients within hours, and the effect was still present after three weeks. They are now conducting larger studies that they hope will shore up their findings.The work forms part of a renaissance in studying the potential therapeutic [...]
A group of medical researchers from St. George’s University of London were commissioned by the federal government for the purpose of definitively proving that cannabis has “no medicinal value”; however, they seem to have proven just the opposite.
The results of the studies stated by the government branch NIDA (National Institute on Drug Abuse) conclusively found that the two most abundant cannabinoids in cannabis, CBD (cannabidiol) and THC (tetrahydrocannabinol), effectively weaken the ferociousness of cancer development resulting in tumor size reduction and in a number of cases, the actually killing of cancer cells. This is not necessarily news, but the fact that the [...]
Written by Vaughan Bell on Mindhacks
A remarkable 1963 study [pdf] from the Archives of Opthalmology in which 24 blind participants took LSD to see if they could experience visual hallucinations.
Those blind from a very early age (younger than two years-old) did not report visual hallucinations, probably because they never had enough visual experience to shape a fully-functioning visual system when their brain was still developing.It turns out, they can, although this seems largely to be the case in blind people who had several years of sight to begin with, but who later lost their vision.
It is evident that a normal retina is not needed for the occurrence of [...]
Dr. Robin Carhart-Harris has boldly gone where no man has gone in over 40 years: he is the first person in the UK to have legally administered doses of LSD to human volunteers since the Misuse of Drugs Act of 1971.
Dr. Carhart-Harris, a research associate in the Centre for Neuropsychopharmacology at Imperial College, presented his research at a public talk in June. The centerpiece of his presentation was a slid showing a cross-sectional image of the brain of a volunteer who was in an fMRI while under [...]
It could be a ‘superhighway to the unconscious’
Acid-head students are pestering university academics to let them join a new study where volunteers are injected with LSD.
Scientists at Imperial College have been experimenting with the hallucinogenic drug to explore hopes that it could be used to treat depression.
But the doc in charge of the experiment said hordes of students wanted to take part.
We had a battering of students who wanted to take part and take LSD. One or two students were recruited to the LSD study out of 20 participants, who were mostly professionals. Dr Robin Carhart-Harris
For some bizarre reason, there is not a state in the US that recognizes Autism as a qualifying condition to use cannabis medically, except in the case of California where doctors can prescribe cannabis to anyone they feel will benefit medicinally.
That’s not to say that activists in some states aren’t fighting and working hard to add Autism to the list, but with the endless stream of anecdotal and peer-reviewed evidence that proves that Autistic people function better using cannabis, it isn’t something we should have to fight for. It’s something we should be embracing right away.
In the Spring of 2014 we started working with our son’s new friend friend Noah to treat his [...]
MAPS has recently completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s.
LSD (lysergic acid diethylamide) is a semi-synthetic compound first developed in 1938 by Dr. Albert Hofmann at the Sandoz pharmaceutical company in Basel, Switzerland. After Dr. Hofmann first discovered its effects in 1943, LSD quickly became recognized for its possible therapeutic effects. LSD also played a significant role in the discovery of the serotonin neurotransmitter system.
Our recently completed Phase 2 pilot study in 12 [...]
When 65 year-old psychotherapist Estalyn Walcoff was diagnosed with a type of untreatable lymphoma 5 years ago, she could barely handle the news.
She explains (seen in the video below), that the prognosis only perpetuated her already present anxiety, something she’d faced throughout her life.
But Estalyn was determined to stay positive, repeating positive affirmations such as “even though no one else has made it, it’s possible that I can.“
Another shift came with Estalyn’s new-found desire to look inwards, to discover who she really was. She knew she didn’t want a bitter heart, and she became curious if incorporating a spiritual outlook into her life would help [...]